You are on page 1of 2

DIRECTORS

Sudhir Mehta
Chairman
Markand Bhatt
S. H. Bhojani
Dr. Prasanna Chandra
Kiran Karnik
Sanjay Lalbhai
Dr. C. Dutt
Director (Research & Development)
Samir Mehta
Managing Director

Sl. Name of Director Independent Age Education Occupation


No. Director Type/ Director Relationship, First Date of
Designation on with another Appointment
the Board Director as a Director
(Yes/No)

1. SUDHIR UTTAMLAL EXECUTIVE NO YES 55 B.SC. EXECUTIVE 23/06/1982


MEHTA (MR.) CHAIRMAN CHAIRMAN
2. SAMIR UTTAMLAL MANAGING NO YES 46 B.COM./ M.B.A. MANAGING 20/08/1986
MEHTA (MR.) DIRECTOR DIRECTOR

3. MARKAND NON- NO NO 63 B.COM./ MANAGING 19/10/2000


INDUPRASAD BHATT EXECUTIVE P.G.DIPLOMA- DIRECTOR,
(MR.) DIRECTOR MANAGEMENT,IIM TORRENT
AHMEDABAD POWER
GENERATION
LTD.
4. SHASHIKANT HARILAL NON- YES NO 66 B.SC./ LL.M. PARTNER, 25/05/2001
BHOJANI (MR.) EXECUTIVE AMARCHAND &
DIRECTOR MANGALDAS &
SURESH
A.SHROFF & CO.
5. CHAITANYA WHOLETIME NO NO 58 M.D.-MEDICINE WHOLETIME 27/06/2000
MAVINKURVE DUTT DIRECTOR DIRECTOR-
(DR.) RESEARCH &
DEVELOPMENT
6. KIRAN NON- YES NO 62 B.SC.-PHYSICS/ PRESIDENT, 24/01/2001
SHARADCHANDRA EXECUTIVE P.G.DIPLOMA- NASSCOM
KARNIK (MR.) DIRECTOR MANAGEMENT,IIM
AHMEDABAD
7. SANJAY SHRENIK NON- YES NO 55 B.SC./ M.M.S. ENTREPRENEUR 23/01/2003
LALBHAI (MR.) EXECUTIVE
DIRECTOR
8. PRASANNA CHANDRA NON- YES NO 63 M.B.A./ PH.D.- CONSULTANT & 25/05/2001
SITAB CHANDRA EXECUTIVE FINANCE ACADEMICIAN
SHRIMAL (DR.) DIRECTOR

Rs. in Crores
2007-08 2006-07
Sales & Operating Income 995.90 882.90
Operating Profits (PBDIT) 216.98 167.49
Less Depreciation 32.74 30.24
Less Net Interest Expense 18.40 13.15
Profit Before Tax & Exceptional Items 165.84 124.10
Less Net Income Tax Expense 10.32 11.14
Net Profit for the Period 155.52 112.96
Balance brought forward from Last Year 62.02 48.39
Distributable Profits 217.53 161.35
Appropriated as under:
Transfer to General Reserve 99.00 70.39
Proposed Equity Dividend 29.61 --
Interim Dividend -- 25.38
Tax on Distributed Profits 5.03 3.56
Balance Carried Forward 83.89 62.02
Earnings Per Share 18.38 13.35

FINANCIAL RESULTS
The summary of consolidated (Company and its subsidiaries) and standalone (Company)
operating results
for the year and appropriation of divisible profits is given below :
(Rs. in Crores except per share data)
Consolidated Standalone
2008-09 2007-08 2008-09 2007-08
Sales & Operating Income 1631 1355 1185 996
Operating Profits (PBDIT) 262 208 257 217
Less Depreciation 42 39 37 33
Less Net Interest Expense 19 20 20 18
Profit Before Exceptional Items & Tax 201 149 200 166
Less Exceptional Items 9 - - 9 - -
Less Tax Expense 7 14 4 10
Net Profit for the Year 185 135 187 156
Balance brought forward 3 2 84 62
Distributable Profits 188 137 271 218
Appropriated as under:
Transfer to General Reserve 145 99 145 99
Proposed Equity Dividend 34 30 34 30
Tax on Distributed Profits 6 5 6 5
Balance Carried Forward 3 3 86 84
Earnings Per Share (Rs. per share) 21.79 15.92 22.07 18.38

Therapeutic Segment
Company's
Growth
Segment
Growth
Cardiovascular 7.1% 13.2%
Gastrointestinal 2.0% 8.2%
CNS 9.5% 10.4%
Anti-infective 4.2% 9.8%
Pain management 1.2% 9.0%
Anti-diabetics 20.1% 16.2%
Source: ORG-IMS March 2009 MAT